# Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

> **NCT05456529** · PHASE3 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 103 (actual)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **DRUG:** Ruxolitinib Cream

## Key facts

- **NCT ID:** NCT05456529
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2024-05-17
- **Final completion:** 2024-05-17
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05456529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05456529, "Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05456529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*